LMAT
LeMaitre Vascular, Inc.NASDAQHealthcare$108.49-0.24%ClosedMarket Cap: $2.47B
As of 2026-04-06
Valuation
P/E (TTM)
42.80
PEG
1.38
P/B
6.30
P/S
9.96
EV/EBITDA
29.12
DCF Value
$87.44
FCF Yield
3.0%
Div Yield
0.8%
Margins & Returns
Gross Margin
71.5%
Operating Margin
27.2%
Net Margin
23.1%
ROE
15.6%
ROA
9.4%
ROIC
9.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $64.5M | 71.7% | $18.8M | $15.6M | $0.68 | $0.20 |
| FY 2025 | $249.6M | 71.5% | $67.9M | $57.7M | $2.52 | $0.80 |
| Q3 2025 | $61.0M | 75.3% | $20.3M | $17.4M | $0.75 | $0.20 |
| Q2 2025 | $64.2M | 70.0% | $16.1M | $13.8M | $0.60 | $0.20 |
| Q1 2025 | $59.9M | 69.2% | $12.6M | $11.0M | $0.48 | $0.20 |
| Q4 2024 | $55.7M | 69.3% | $12.9M | $11.2M | $0.49 | $0.16 |
| FY 2024 | $219.9M | 68.6% | $52.3M | $44.0M | $1.93 | $0.64 |
| Q3 2024 | $54.8M | 67.8% | $13.1M | $11.1M | $0.49 | $0.16 |
| Q2 2024 | $55.8M | 68.9% | $14.4M | $11.8M | $0.52 | $0.16 |
| Q1 2024 | $53.5M | 68.6% | $11.9M | $9.9M | $0.43 | $0.16 |
| Q4 2023 | $48.9M | 68.1% | $10.2M | $8.5M | $0.38 | $0.14 |
| FY 2023 | $193.5M | 65.7% | $36.7M | $30.1M | $1.34 | $0.56 |